Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Keros Therapeutics, Inc. company logo
Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc. (KROS)

Summary

As of today, KROS price is $16.55, up +2.35% on
KROS price is currently -81.36% below its historical high of $88.80 set on
KROS current market cap is $504M, up +12.70% over the past 365 days
KROS current PE ratio is 10.73
KROS current annual revenue is $3.55M, up +2250.99% year-over-year
The next earnings release for KROS is on

Profile

Company profile for Keros Therapeutics, Inc. (KROS)
MetricValue
Full NameKeros Therapeutics, Inc.
TickerNASDAQ: KROS
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websitekerostx.com
Employees163

Key Metrics

Keros Therapeutics, Inc. Key Details
MetricDateValue
Price$16.55
Price, 1D Change+2.35%
$504M
-
10.73
0.19
$4M
Revenue, 1Y Change+2,250.99%
-$5.00
EPS, 1Y Change+3.68%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Keros Therapeutics, Inc. chart

Events

Keros Therapeutics, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

KROS Estimates
MetricDateValue
-$5.00
EPS Estimate$2.37
EPS Est. Change+147.42%
$3.55M
Revenue Estimate$246.51M
Revenue Est. Change+6,843.85%
Current Price$16.55
Price Target-$22.50
Price Tgt. Change-+35.95%

🔒 Log In To Unlock Full Data

EPS

KROS EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$5.24-$5.20+0.85%
-$4.12-$5.00-21.47%
$2.37N/A+147.42%
-$3.44N/A+31.29%
KROS EPS reported versus estimate values chart

Revenue

KROS revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$0.00$151.00K-100.00%
$32.05M$3.55M-88.92%
$246.51MN/A+6,843.85%
$12.53MN/A+253.08%
KROS revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

KROS Performance
MetricDateValue
Price, 1Y+50.05%
Price, 3Y-69.90%
+12.70%
-66.71%
+2,250.99%
-82.34%
+3.68%
-98.78%

🔒 Log In To Unlock Full Data

Technical Indicators

KROS Technical Indicators
MetricDateValue
Current Price$16.55
$16.06
SMA 200 vs Price-2.97%
$19.11
SMA 50 vs Price+15.49%
0.19
$0.66
35.77
32.78%
45.98%

Dividends

KROS Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

KROS Income & Profitability
MetricDateValue
$3.55M
-$5.00
$2.32M
65.38%
-$209.60M
-5,938.96%
-$187.35M
-5,277.55%
-$185.82M

🔒 Log In To Unlock Full Data

Financial Health

KROS Financial Health
MetricDateValue
0.00
21.45
21.45
-
8
5.63

Valuations

KROS Valuations
MetricDateValue
10.73
2.04
0.72
-3.82
N/A-

Balance Sheet

KROS Balance Sheet
MetricDateValue
$571.55M
$559.93M
$615.89M
$588.89M
$44.33M
$27.45M
$18.86M
$1.98M
$4.60M

Expenses

KROS Expenses
MetricDateValue
$213.15M
$213.15M
$1.23M
$40.75M
$1.23M
$0.00
$300.00K

Cash Flow

KROS Cash Flow
MetricDateValue
-$160.87M
-$1.93M
$391.82M
$1.93M
-$162.80M

Recent analyst updates

KROS Recent analyst updates
MetricDateValue
B of A Securities→
Oppenheimer→
Wells Fargo→
Wedbush→
HC Wainwright & Co.→
B of A Securities→
Wedbush→
Scotiabank→
HC Wainwright & Co.→
Truist Securities→

Analyst sentiment

Sentiment over the past month
KROS analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
KROS institutional ownership distribution chart

Screeners with KROS

FAQ

  • What is the ticker symbol for Keros Therapeutics, Inc.?

    The ticker symbol for Keros Therapeutics, Inc. is NASDAQ:KROS

  • Does Keros Therapeutics, Inc. pay dividends?

    No, Keros Therapeutics, Inc. does not pay dividends

  • What sector is Keros Therapeutics, Inc. in?

    Keros Therapeutics, Inc. is in the Healthcare sector

  • What industry is Keros Therapeutics, Inc. in?

    Keros Therapeutics, Inc. is in the Biotechnology industry

  • What country is Keros Therapeutics, Inc. based in?

    Keros Therapeutics, Inc. is headquartered in United States

  • When did Keros Therapeutics, Inc. go public?

    Keros Therapeutics, Inc. initial public offering (IPO) was on April 8, 2020

  • Is Keros Therapeutics, Inc. in the S&P 500?

    No, Keros Therapeutics, Inc. is not included in the S&P 500 index

  • Is Keros Therapeutics, Inc. in the NASDAQ 100?

    No, Keros Therapeutics, Inc. is not included in the NASDAQ 100 index

  • Is Keros Therapeutics, Inc. in the Dow Jones?

    No, Keros Therapeutics, Inc. is not included in the Dow Jones index

  • When was Keros Therapeutics, Inc. last earnings report?

    Keros Therapeutics, Inc.'s most recent earnings report was on November 5, 2025

  • When does Keros Therapeutics, Inc. report earnings?

    The next expected earnings date for Keros Therapeutics, Inc. is February 25, 2026

Data Sources & References

  1. KROS Official Website www.kerostx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1664710/000166471025000089/0001664710-25-000089-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1664710/000166471025000018/0001664710-25-000018-index.htm
  4. KROS Profile on Yahoo Finance finance.yahoo.com/quote/KROS
  5. KROS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/kros